PATENT CLAIM ANALYSIS

Application Number: 16154343
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["424", "247100"]

Abstract:
A headache can be treated more effectively by co-administration of a botulinum toxin and a triptan drug to a patient and/or the effectiveness of a triptan medication can be increased. The botulinum toxin can be botulinum toxin type A and the botulinum toxin can be administered to or to the vicinity of where a patient experiences or is predisposed to experience pain or a headache.

Claim (Index 1):
A method for reducing the occurrence of or alleviating a headache in a patient with chronic migraine headaches, the method comprising local administration by injection of a composition comprising a botulinum toxin type A, wherein the number of injection sites is 23 to 58, the number of muscle areas injected is 6 to 7 and the botulinum toxin type A dose is 105 to 260 units, and wherein at least the frontal/glabellar, occipitalis, temporalis, semispinalis, splenius capitis or trapezius muscles are injected.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 97.0
- Lexical Diversity: 1.91429
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15412392', '12256655', '14797552', '11329598', '13757312']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8202130902542946
- 35 USC 102 Novelty (BERT): 0.6690165670626672
- Combined Prediction Score: 0.8050934379351318
- Mean Citation Score: 616.21006
- Max Citation Score: 642.0961
- Similarity Product: 640.4512115821659

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test